Leveraging the Emergency Department to Engage African American Women in HIV Pre-Exposure Prophylaxis (IWPrEP)
HIV Infections

About this trial
This is an interventional prevention trial for HIV Infections focused on measuring African American women, HIV risk, substance use, sexual risk
Eligibility Criteria
Inclusion Criteria:
- Current HIV negative status (based on ED' HIV test outcome)
- Condomless sex in the last 3 months
- Substance use in the last 3 months
- HIV testing during ED visit (usual care)
- Has a non-emergent health condition
- Has a working mobile device with them
Exclusion Criteria:
- Ineligible for PrEP (see eligibility criteria to the right)
- Assigned male at birth
- An HIV positive status
- Currently taking medication that are known contraindications for PrEP (brand name: Truvada)
- Currently on PrEP
Sites / Locations
- The University of Texas Health Science Center at Houston
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
iPrEP Intervention
Usual Care
iPrEP Intervention: Women will receive the iPrEP intervention on an iPAD Air tablet device iPrEP serves a dual role as a data collection instrument and an intervention--the survey incorporates brief, informational messages into a traditional survey instrument iPrEP uses qualitative themes iPrEP is divided into sections addressing factors with historical success at predicting pre-exposure prophylaxis (PrEP) adherence Scales chosen to measure themes and sections were retained from the original HIV Prevention Trials Network (HPTN) 073 instrument Scales were modified (in some cases) for cultural competency and tailoring to women
Control Intervention: Women will receive usual care Usual care includes an assessment visit with an emergency department (ED)-assigned social worker who specializes in substance use Social worker will offer a list of substance abuse treatment referral agencies